Immunogenetic mechanisms of antibody response to measles vaccine: The role of the HLA genes

Gregory A. Poland

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Measles is the most transmissible human disease known to date. In the prevaccine era, virtually every member of each birth cohort was infected with this virus, leading to substantial morbidity and mortality, with millions of deaths on a global scale. At the current time, measles causes an estimated 1 to 1.5 million deaths per year world-wide. Since the advent of live, attenuated measles vaccines measles has been controlled, but not eradicated. Central to the goal of measles eradication are data relating to the influence of immunogenetics on vaccine immunogenicity. In this paper, the results of studies are reviewed executed in my laboratory examining the role of the class I and II HLA genes on the antibody response to measles vaccine.

Original languageEnglish (US)
Pages (from-to)1719-1725
Number of pages7
JournalVaccine
Volume17
Issue number13-14
DOIs
StatePublished - Jan 1 1999

    Fingerprint

Keywords

  • HLA
  • Immunogenetics
  • Measles
  • Vaccine response

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this